818 related articles for article (PubMed ID: 25726383)
1. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.
Durand E; Eltchaninoff H; Canville A; Bouhzam N; Godin M; Tron C; Rodriguez C; Litzler PY; Bauer F; Cribier A
Am J Cardiol; 2015 Apr; 115(8):1116-22. PubMed ID: 25726383
[TBL] [Abstract][Full Text] [Related]
2. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
[TBL] [Abstract][Full Text] [Related]
3. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter aortic valve implantation using a direct aortic approach: a single-centre Heart Team experience.
Amrane H; Porta F; van Boven AJ; Boonstra PW; Hofma SH; Head SJ; Kappetein AP
Interact Cardiovasc Thorac Surg; 2014 Nov; 19(5):777-81. PubMed ID: 25074233
[TBL] [Abstract][Full Text] [Related]
6. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
7. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
8. Early discharge after transfemoral transcatheter aortic valve implantation.
Barbanti M; Capranzano P; Ohno Y; Attizzani GF; Gulino S; Immè S; Cannata S; Aruta P; Bottari V; Patanè M; Tamburino C; Di Stefano D; Deste W; Giannazzo D; Gargiulo G; Caruso G; Sgroi C; Todaro D; di Simone E; Capodanno D; Tamburino C
Heart; 2015 Sep; 101(18):1485-90. PubMed ID: 26076940
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Analysis of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation.
Serletis-Bizios A; Durand E; Cellier G; Tron C; Bauer F; Glinel B; Dacher JN; Cribier A; Eltchaninoff H
Am J Cardiol; 2016 Sep; 118(6):866-872. PubMed ID: 27453514
[TBL] [Abstract][Full Text] [Related]
10. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
11. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
[TBL] [Abstract][Full Text] [Related]
12. Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis.
Pendyala LK; Minha S; Barbash IM; Torguson R; Magalhaes MA; Okubagzi P; Loh JP; Chen F; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2014 Jan; 113(2):342-7. PubMed ID: 24220281
[TBL] [Abstract][Full Text] [Related]
13. Transaortic transcatheter aortic valve implantation: Results of the Polish arm of the ROUTE registry.
Jagielak D; Bramlage P; Pawlaczyk R; Brzeziński M; Fijałkowski M; Łaskawski G; Ciećwierz D; Rogowski J; Kozaryn R
Cardiol J; 2015; 22(6):651-6. PubMed ID: 26202653
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves.
Schwietz T; Behjati S; Gafoor S; Seeger F; Doss M; Sievert H; Zeiher AM; Fichtlscherer S; Lehmann R
EuroIntervention; 2015 Apr; 10(12):1468-73. PubMed ID: 24970670
[TBL] [Abstract][Full Text] [Related]
16. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
Borz B; Durand E; Godin M; Tron C; Canville A; Litzler PY; Bessou JP; Cribier A; Eltchaninoff H
Heart; 2013 Jun; 99(12):860-5. PubMed ID: 23236027
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological evaluation of atrioventricular conduction disturbances in transcatheter aortic valve implantation with Edwards SAPIEN prosthesis.
Eksik A; Gul M; Uyarel H; Surgit O; Yildirim A; Uslu N; Aksu H; Turen S; Uzun F; Satılmısoglu H; Erol MK; Bakir I
J Invasive Cardiol; 2013 Jun; 25(6):305-9. PubMed ID: 23735359
[TBL] [Abstract][Full Text] [Related]
18. Performance and Safety of Transfemoral TAVI With SAPIEN XT in Australian Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: SOLACE-AU Trial.
Yong G; Walton T; Ng M; Gurvitch R; Worthley S; Whitbourn R; Jepson N; Bhindi R; Shang K; Sinhal A
Heart Lung Circ; 2020 Dec; 29(12):1839-1846. PubMed ID: 32712017
[TBL] [Abstract][Full Text] [Related]
19. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
[TBL] [Abstract][Full Text] [Related]
20. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
Babaliaros V; Devireddy C; Lerakis S; Leonardi R; Iturra SA; Mavromatis K; Leshnower BG; Guyton RA; Kanitkar M; Keegan P; Simone A; Stewart JP; Ghasemzadeh N; Block P; Thourani VH
JACC Cardiovasc Interv; 2014 Aug; 7(8):898-904. PubMed ID: 25086843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
